Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial.
Pilar JimenezSalvatore BrugalettaAngel CequierAndrés Iñiguez RomoAntonio SerraVicente MainarGianluca CampoMaurizio TespiliLuis Nombela-FrancoMaria Del TrigoNieves GonzaloJavier EscanedPablo SalinasIvan Javier Nuñez-GilCristina Fernandez-PerezAntonio Fernández-OrtizCarlos MacayaPatrick W J C SerruysManel Sabate TenasPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
Diabetics had worse clinical outcomes than nondiabetics after STEMI mainly due to atherosclerosis progression. At 5-years, the treatment with EES did not reduce the rate of POCE in diabetics but reduced the need for revascularization compared with BMS.
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- glycemic control
- st elevation myocardial infarction
- acute coronary syndrome
- cardiovascular disease
- coronary artery disease
- coronary artery bypass grafting
- type diabetes
- atrial fibrillation
- adipose tissue
- skeletal muscle
- weight loss
- insulin resistance